“Disruptive and high accuracy test for early colorectal cancer detection in blood” –PreveCol project has received the support of the EIC program from the European Commission under grant agreement No, 190177779
“ColoFast project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 767419”
The Spanish Ministry of Science and Innovation granted a TORRES QUEVEDO Project to Advanced Marker Discovery, S.L. with reference PTQ-11-04492, that is co-financed by the European Social Fund.
AMX Data – Identification of risk factors for the development of colorectal cancer and / or premalignant lesions using Big Data tools and Artificial Intelligence for Early Cancer Detection” has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 957099.
This company is capitalized by Innvierte, an investment program of CDTI, E.P.E.
Advanced Marker Discovery, S.L. has received a grant from EIT Health – European Institute of Innovation and Technology, for the project “Disruptive and high accuracy test for early colon cancer detection”, with Subgranting Agreement No 2020 Digital Sandbox – DS20-12416.
Advanced Marker Discovery, S.L. has received a grant from the Enterprise Competitiveness Institute (ICE), which is co-financed with the European Union FEDER funds, for the project “BigDatCancer”, with reference 04/18/VA/0108 for the project “Development of an algorithm for early detection of colon cancer based on risk factors identified using big data and artificial intelligence tools and molecular markers”.
Advanced Marker Discovery, S.L. has received a grant from the Enterprise Competitiveness Institute (ICE), which is co-financed with the European Union FEDER funds, for the project “ALMATIC”, with reference CCTT4/20/VA/0010 for the project “Definition and development of algorithms for data analysis platform in maintenance, Predictive Quality and health problems”.
“AI4ICD – Identification of Colon Cancer risk factors using AI, has received funding from the European Union’s Horizon 2020 research and innovation programme within the framework of the AI4EU Project funded under grant agreement No 825619”.
The Spanish Ministry of Science and Innovation (MCIN) has awarded Advanced Marker Discovery a grant for a project under the TORRES QUEVEDO CALL 2020 programme with reference number PTQ2020-0100990 which is co-financed by the State Research Agency; the European Union and NextGenerationEU.
Advanced Marker Discovery, S.L. has received a grant from EIT Health – European Institute of Innovation and Technology, for the project “Disruptive and high accuracy test for early colon cancer detection”, with Subgranting Agreement No. 2021 Mentoring and Coaching Network 210805.
Advanced Marker Discovery, S.L. has received a grant co-financed by the European Regional Development Fund, to encourage the use of R&D and innovation services by SMEs, “Cheque Innovación” Program in the framework of the research and innovation strategy for smart specialization (RIS3), within the program of the Community of Madrid for the period 2014-2020, through the project “DEVELOPMENT OF A GENETIC SIGNATURE FOR EARLY AND DIFFERENTIAL DIAGNOSIS OF CANCER OF CANCER OF CANCER IN NON INVASIVE SAMPLE”.
ColoDix – Early detection of colorectal cancer in blood based on latest generation biomarkers and Artificial Intelligence tools” has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 190177779.
Advanced Marker Discovery, S.L. has received a grant for the project “Development of a genetic signature for the early and differential diagnosis of pancreatic cancer in a non-invasive sample” submitted to the “Cheque Innovación” program, aid co-financed by the European Regional Development Fund (FEDER) in the Framework of the “Research and Innovation Strategies for Smart Specialization” (RIS3) of the Comunidad de Madrid, for the period 2014-2020, with reference number 09/772037.9/21.
Advanced Marker Discovery, S.L. has received a participative loan from National Innovation Company, S.M.E., S.A. (ENISA) under the “growth plan” with Application number_2021_04_N05
Advanced Marker Discovery, S.L., has received funding to carry out the project CPP2021/008322 – “Development and clinical validation of an epigenetic signature for the non-invasive diagnosis of pancreatic cancer and precursor lesions – PancaTEST” by the MIC/AEI/10.13039/501100011033 and by the European Union Next GenerationEU/PRTR.
Advanced Marker Discovery, S.L., has received funding to carry out the project CPP2021/008336 – “Development of a test for non-invasive early diagnosis of lung cancer based on molecular markers, imaging and Big Data tools – oncoLungDx” by the MIC/AEI/10.13039/501100011033 and by the European Union Next GenerationEU/PRTR
Advanced Marker Discovery, S.L., has received funding to carry out the project CPP2021/008536 – “Disruptive Technologies for the Early Detection of Colorectal Cancer – TEDCRC” by the MIC/AEI/10.13039/501100011033 and by the European Union Next GenerationEU/PRTR
Advanced Marker Discovery, S.L. has received a grant from the Ministry of Industry, Trade and Tourism within the AEI support program to contribute to improving the competitiveness of Spanish industry for the project “Digital platform for managing clinical data analyzed with Artificial Intelligence/Big Data for the early detection of cancer” with file number AEI-010500-2022b-318.
Advanced Marker Discovery, S.L. has received a grant from the public business entity Red.es, M.P. corresponding to the 2021 call for grants for research and development projects in artificial intelligence and other digital technologies and their integration into value chains – C005/21-ED – for the project ‘Development of an algorithm for early detection of lung cancer and indeterminate lung nodule malignancy based on digital markers – dataLung” with file number 2021/C005/00152799.
Advanced Marker Discovery, S. L. (AMADIX) has received a bonus of 12,000 euros from the Digital Kit Program funded by the European Union – Next Generation EU for SMEs and freelancers to implement digital solutions.
Advanced Marker Discovery, S. L. (AMADIX) has received funding from the Ministry of Industry, Trade and Tourism through the EOI Foundation, as well as by the Institute for Business Competitiveness (icecyl) of the Junta de Castilla y León F.S.P through the “Activa Startups” initiative in the framework of the Recovery, Transformation and Resilience Plan to carry out the project “Development of a platform for pre-analysis and analysis of molecular data – dataPlatform”.
